Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative intravenous lidocaine for prevention of postoperative acute kidney injury in enterogenic sepsis
ChiCTR2500105718Phase 4Completed
- Sponsor
- People's Hospital of Xinjiang Uyghur Autonomous Region
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in sepsis and acute kidney failure (AKF) (2 arms), sponsored by People's Hospital of Xinjiang Uyghur Autonomous Region. Primary endpoint: Incidence of postoperative acute kidney injury (AKI). Started Jul 2025; status: completed.
02
Drugs
lidocaine
03
Conditions
sepsisacute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2500105718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105718.